Nevin John

Nevin John

University College London

H-index: 8

Europe-United Kingdom

Contact Nevin John

About Nevin John

Nevin John, With an exceptional h-index of 8 and a recent h-index of 8 (since 2020), a distinguished researcher at University College London, specializes in the field of multiple sclerosis.

His recent articles reflect a diverse array of research interests and contributions to the field:

Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom

Multiple sclerosis and demyelinating diseases

Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries

Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies

Disease activity during pre-conception, pregnancy and postpartum in women with MS receiving ocrelizumab or other disease-modifying therapies in a real-world cohort

Cardiovascular risk factors in secondary progressive multiple sclerosis: A cross‐sectional analysis from the MS‐STAT2 randomized controlled trial

Rituximab vs ocrelizumab in relapsing-remitting multiple sclerosis

Comparative effectiveness of autologous hematopoietic stem cell transplant vs fingolimod, natalizumab, and ocrelizumab in highly active relapsing-remitting multiple sclerosis

Nevin John Information

University	University College London
Position	Clinical Research Fellow
Citations(all)	531
Citations(since 2020)	473
Cited By	185
hIndex(all)	8
hIndex(since 2020)	8
i10Index(all)	8
i10Index(since 2020)	8
Email	Access Email
University Profile Page	University College London
Google Scholar	View Google Scholar Profile

Nevin John Skills & Research Interests

multiple sclerosis

Top articles of Nevin John

Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom

Journal of medical economics

2024/12/31

Multiple sclerosis and demyelinating diseases

Neurology: a Queen square textbook

2024/5/13

Wallace Brownlee

H-Index: 18

Olga Ciccarelli

H-Index: 12

Nevin John

H-Index: 5

Heather Wilson

H-Index: 13

Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries

The Lancet Child & Adolescent Health

2024/5/1

Massimo Filippi

H-Index: 82

Serkan Ozakbas

H-Index: 15

Vincenzo Brescia Morra

H-Index: 26

Francesco Patti

H-Index: 2

Alexandre Prat

H-Index: 56

Cavit Boz

H-Index: 28

Carlo Pozzilli

H-Index: 47

Eleonora Cocco

H-Index: 30

Paolo Gallo

H-Index: 8

Silvia Romano

H-Index: 25

Antonio Gallo

H-Index: 20

Antonella Conte

H-Index: 5

Nevin John

H-Index: 5

Anneke Van Der Walt

H-Index: 18

Helmut Butzkueven

H-Index: 45

Franco Granella

H-Index: 28

Girolama Alessandra Marfia

H-Index: 26

Vincent Van Pesch

H-Index: 30

Michael Barnett

H-Index: 48

Jiwon Oh

H-Index: 4

Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies

Journal of neurology

2024/1

Ying Li

H-Index: 9

Bruce Taylor

H-Index: 20

Simon Broadley

H-Index: 1

Francesco Patti

H-Index: 2

Serkan Ozakbas

H-Index: 15

Nevin John

H-Index: 5

Stella Hughes

H-Index: 2

Anneke Van Der Walt

H-Index: 18

Helmut Butzkueven

H-Index: 45

Celia Oreja-Guevara

H-Index: 36

Seyed Aidin Sajedi

H-Index: 11

Ingrid Van Der Mei

H-Index: 33

Disease activity during pre-conception, pregnancy and postpartum in women with MS receiving ocrelizumab or other disease-modifying therapies in a real-world cohort

2023/10/1

Anneke Van Der Walt

H-Index: 18

Cavit Boz

H-Index: 28

Nevin John

H-Index: 5

Vincent Van Pesch

H-Index: 30

Alexandre Prat

H-Index: 56

Serkan Ozakbas

H-Index: 15

Francesco Patti

H-Index: 2

Michael Barnett

H-Index: 48

Stella Hughes

H-Index: 2

Mark Slee

H-Index: 33

Jiwon Oh

H-Index: 4

Helmut Butzkueven

H-Index: 45

Vilija Jokubaitis

H-Index: 23

Cardiovascular risk factors in secondary progressive multiple sclerosis: A cross‐sectional analysis from the MS‐STAT2 randomized controlled trial

European journal of neurology

2023/9

Thomas Williams

H-Index: 12

Nevin John

H-Index: 5

Sarah Wright

H-Index: 7

Madiha Shatila

H-Index: 2

Antonio Ricciardi

H-Index: 0

Ferran Prados

H-Index: 22

David Macmanus

H-Index: 18

Olga Ciccarelli

H-Index: 12

Frederik Barkhof

H-Index: 101

Wallace Brownlee

H-Index: 18

Ian Galea

H-Index: 23

Helen Ford

H-Index: 7

Gillian Ingram

H-Index: 16

Stella Hughes

H-Index: 2

Claire Rice

H-Index: 20

Stefano Pluchino

H-Index: 43

Paul Gallagher

H-Index: 13

Fayyaz Ahmed

H-Index: 1

Martin Lee

H-Index: 6

Abhijit Chaudhuri

H-Index: 13

Rituximab vs ocrelizumab in relapsing-remitting multiple sclerosis

JAMA neurology

2023/8/1

Stella Hughes

H-Index: 2

Cavit Boz

H-Index: 28

Serkan Ozakbas

H-Index: 15

Anneke Van Der Walt

H-Index: 18

Helmut Butzkueven

H-Index: 45

Nevin John

H-Index: 5

Michael Barnett

H-Index: 48

Mark Slee

H-Index: 33

Bruce Taylor

H-Index: 20

Vincent Van Pesch

H-Index: 30

Alexandre Prat

H-Index: 56

Catherine Larochelle

H-Index: 10

Jiwon Oh

H-Index: 4

Albert Saiz

H-Index: 17

Francesco Patti

H-Index: 2

Emanuele D'Amico

H-Index: 19

John King

H-Index: 10

Chris Dwyer

H-Index: 13

Mastura Monif

H-Index: 11

Lisa Taylor

H-Index: 6

Comparative effectiveness of autologous hematopoietic stem cell transplant vs fingolimod, natalizumab, and ocrelizumab in highly active relapsing-remitting multiple sclerosis

JAMA neurology

2023/7/1

Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis

Multiple Sclerosis Journal

2023/6

Serkan Ozakbas

H-Index: 15

Cavit Boz

H-Index: 28

Francesco Patti

H-Index: 2

Alexandre Prat

H-Index: 56

Seyed Aidin Sajedi

H-Index: 11

Anneke Van Der Walt

H-Index: 18

Helmut Butzkueven

H-Index: 45

Nevin John

H-Index: 5

Vincent Van Pesch

H-Index: 30

Michael Barnett

H-Index: 48

Celia Oreja-Guevara

H-Index: 36

Stella Hughes

H-Index: 2

Bruce Taylor

H-Index: 20

Jiwon Oh

H-Index: 4

The Queen Square Adult Leukodystrophy Group: 10 years-experience of a multidisciplinary diagnostic service (P10-4.006)

2023/4/25

Thomas Williams

H-Index: 12

Frederik Barkhof

H-Index: 101

Nevin John

H-Index: 5

Wallace Brownlee

H-Index: 18

Matthew Adams

H-Index: 17

Indran Davagnanam

H-Index: 21

David Lynch

H-Index: 12

Predictors of treatment switching in the big multiple sclerosis data network

Frontiers in Neurology

2023/12/22

Helmut Butzkueven

H-Index: 45

Anneke Van Der Walt

H-Index: 18

Seyed Aidin Sajedi

H-Index: 11

Serkan Ozakbas

H-Index: 15

Celia Oreja-Guevara

H-Index: 36

Stella Hughes

H-Index: 2

Nevin John

H-Index: 5

Leszek Stawiarz

H-Index: 15

Luigi Pontieri

H-Index: 7

Jan Hillert

H-Index: 52

Mapping topography and network of brain injury in patients with disorders of consciousness

Frontiers in Neurology

2023/3/29

Udaya Seneviratne

H-Index: 20

Nevin John

H-Index: 5

Henry Ma

H-Index: 4

Outer plexiform layer and slowly expanding lesions: an oct and mri study in secondary progressive ms.

Multiple Sclerosis Journal

2023/11/25

Arman Eshaghi

H-Index: 12

Jonathan Stutters

H-Index: 5

Thomas Williams

H-Index: 12

David Macmanus

H-Index: 18

Ferran Prados

H-Index: 22

Carmen Tur

H-Index: 26

Frederik Barkhof

H-Index: 101

Longitudinal metabolite changes in progressive multiple sclerosis: a study of 3 potential neuroprotective treatments

Journal of Magnetic Resonance Imaging

2023/10/3

Jonathan Stutters

H-Index: 5

Thomas Williams

H-Index: 12

David Macmanus

H-Index: 18

Frederik Barkhof

H-Index: 101

Vascular comorbidities are associated with increased disability in secondary progressive multiple sclerosis

2023/10/1

Tunde Csepany

H-Index: 14

Stella Hughes

H-Index: 2

Celia Oreja-Guevara

H-Index: 36

Serkan Ozakbas

H-Index: 15

Seyed Aidin Sajedi

H-Index: 11

Anneke Van Der Walt

H-Index: 18

Vincent Van Pesch

H-Index: 30

Thanh Phan

H-Index: 3

Nevin John

H-Index: 5

Early non-disabling relapses are associated with a higher risk of disability accumulation in people with relapsing-remitting multiple sclerosis

2022

Optimising recruitment in clinical trials for progressive multiple sclerosis: observational analysis from the MS-SMART and MS-STAT2 randomised controlled trials

Trials

2022/8/9

Thomas Williams

H-Index: 12

Sarah Alexander

H-Index: 3

Nevin John

H-Index: 5

007 The MS-STAT2 trial in secondary progressive MS–study design and update

2022/6/1

Thomas Williams

H-Index: 12

Nevin John

H-Index: 5

Wallace Brownlee

H-Index: 18

Association of slowly expanding lesions on MRI with disability in people with secondary progressive multiple sclerosis

Neurology

2022/4/26

Carmen Tur

H-Index: 26

Jonathan Stutters

H-Index: 5

Nevin John

H-Index: 5

Thomas Williams

H-Index: 12

David Macmanus

H-Index: 18

Olga Ciccarelli

H-Index: 12

Frederik Barkhof

H-Index: 101

NAA is a marker of disability in secondary-progressive MS: A proton MR spectroscopic imaging study

American Journal of Neuroradiology

2020/12/1

See List of Professors in Nevin John University(University College London)

academic-engine

Useful Links

List of top 50 universities

List of top 100 universities

List of top 500 universities

Find Professors Email

Find Universities Email

CUFinder Academic Engine